Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP595506.RAfJ8OLvUtnClkcwsm5p-kELUyYcM1IlkDlSlKTeG65Rg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP595506.RAfJ8OLvUtnClkcwsm5p-kELUyYcM1IlkDlSlKTeG65Rg130_assertion type Assertion NP595506.RAfJ8OLvUtnClkcwsm5p-kELUyYcM1IlkDlSlKTeG65Rg130_head.
- NP595506.RAfJ8OLvUtnClkcwsm5p-kELUyYcM1IlkDlSlKTeG65Rg130_assertion description "[Although most of these genes were affected at low frequency in an expanded CLL screening cohort, mutational activation of NOTCH1, observed in 8.3% of CLL at diagnosis, was detected at significantly higher frequency during disease progression toward Richter transformation (31.0%), as well as in chemorefractory CLL (20.8%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP595506.RAfJ8OLvUtnClkcwsm5p-kELUyYcM1IlkDlSlKTeG65Rg130_provenance.
- NP595506.RAfJ8OLvUtnClkcwsm5p-kELUyYcM1IlkDlSlKTeG65Rg130_assertion evidence source_evidence_literature NP595506.RAfJ8OLvUtnClkcwsm5p-kELUyYcM1IlkDlSlKTeG65Rg130_provenance.
- NP595506.RAfJ8OLvUtnClkcwsm5p-kELUyYcM1IlkDlSlKTeG65Rg130_assertion SIO_000772 21670202 NP595506.RAfJ8OLvUtnClkcwsm5p-kELUyYcM1IlkDlSlKTeG65Rg130_provenance.
- NP595506.RAfJ8OLvUtnClkcwsm5p-kELUyYcM1IlkDlSlKTeG65Rg130_assertion wasDerivedFrom befree-20150227 NP595506.RAfJ8OLvUtnClkcwsm5p-kELUyYcM1IlkDlSlKTeG65Rg130_provenance.
- NP595506.RAfJ8OLvUtnClkcwsm5p-kELUyYcM1IlkDlSlKTeG65Rg130_assertion wasGeneratedBy ECO_0000203 NP595506.RAfJ8OLvUtnClkcwsm5p-kELUyYcM1IlkDlSlKTeG65Rg130_provenance.